Cargando…

Characterizing CDK8/19 Inhibitors through a NFκB-Dependent Cell-Based Assay

Cell-based assays for CDK8/19 inhibition are not easily defined, since there are no known cellular functions unique to these kinases. To solve this problem, we generated derivatives of 293 cells with CRISPR knockout of one or both of CDK8 and CDK19. Double knockout (dKO) of CDK8 and CDK19 together (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jing, Ji, Hao, Porter, Donald C., Broude, Eugenia V., Roninson, Igor B., Chen, Mengqian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830309/ https://www.ncbi.nlm.nih.gov/pubmed/31590445 http://dx.doi.org/10.3390/cells8101208

Ejemplares similares

Role of transcription-regulating kinase CDK8 in colon cancer metastasis
por: Liang, Jiaxin, et al.
Publicado: (2019)

Identifying Cancers Impacted by CDK8/19
por: Roninson, Igor B., et al.
Publicado: (2019)

Systemic Toxicity Reported for CDK8/19 Inhibitors CCT251921 and MSC2530818 Is Not Due to Target Inhibition
por: Chen, Mengqian, et al.
Publicado: (2019)

Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer
por: McDermott, Martina S.J., et al.
Publicado: (2017)

CDK8 and CDK19: positive regulators of signal-induced transcription and negative regulators of Mediator complex proteins
por: Chen, Mengqian, et al.
Publicado: (2023)

The Inhibition of CDK8/19 Mediator Kinases Prevents the Development of Resistance to EGFR-Targeting Drugs
por: Sharko, Amanda C., et al.
Publicado: (2021)

Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivo
por: Ding, Xiaokai, et al.
Publicado: (2022)

CDK1 is up-regulated by temozolomide in an NF-κB dependent manner in glioblastoma
por: Voce, David J., et al.
Publicado: (2021)

Inhibition of Cyclin-Dependent Kinases 8/19 Restricts Bacterial and Virus-Induced Inflammatory Responses in Monocytes
por: Kokinos, Elena K., et al.
Publicado: (2023)

Cyclin-Dependent Kinase 9 (CDK9) Inhibitor Atuveciclib Suppresses Intervertebral Disk Degeneration via the Inhibition of the NF-κB Signaling Pathway
por: Ni, Weiyu, et al.
Publicado: (2020)

Structure of a zosuquidar and UIC2-bound human-mouse chimeric ABCB1
por: Alam, Amer, et al.
Publicado: (2018)

Cdk8 attenuates lipogenesis by inhibiting SREBP-dependent transcription in Drosophila
por: Li, Xiao, et al.
Publicado: (2022)

Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme
por: Lubanska, Dorota, et al.
Publicado: (2017)

Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells
por: Levina, Elina, et al.
Publicado: (2015)

CDK7 Inhibition Is Effective in all the Subtypes of Breast Cancer: Determinants of Response and Synergy with EGFR Inhibition
por: McDermott, Martina S. J., et al.
Publicado: (2020)

Identification and Characterization of an Irreversible Inhibitor of CDK2
por: Anscombe, Elizabeth, et al.
Publicado: (2015)

CDK1 bridges NF-κB and β-catenin signaling in response to H. pylori infection in gastric tumorigenesis
por: Zhu, Shoumin, et al.
Publicado: (2023)

Assaying Homodimers of NF-κB in Live Single Cells
por: Martin, Erik W., et al.
Publicado: (2019)

CDK4 regulation by TNFR1 and JNK is required for NF-κB–mediated epidermal growth control
por: Zhang, Jennifer Y., et al.
Publicado: (2005)

Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
por: Tavakolian, Shaian, et al.
Publicado: (2020)

ATM regulates NF-κB-dependent immediate-early genes via RelA Ser 276 phosphorylation coupled to CDK9 promoter recruitment
por: Fang, Ling, et al.
Publicado: (2014)

HIV gp120 Induces, NF-κB Dependent, HIV Replication that Requires Procaspase 8
por: Bren, Gary D., et al.
Publicado: (2009)

Regulatory functions of the Mediator kinases CDK8 and CDK19
por: Fant, Charli B., et al.
Publicado: (2018)

NF-κB Inhibitors from Eurycoma longifolia
por: Tran, Thi Van Anh, et al.
Publicado: (2014)

Several Alphaherpesviruses Interact Similarly with the NF-κB Pathway and Suppress NF-κB-Dependent Gene Expression
por: Romero, Nicolás, et al.
Publicado: (2023)

Molecular and in vivo Functions of the CDK8 and CDK19 Kinase Modules
por: Dannappel, Marius Volker, et al.
Publicado: (2019)

CDK3, CDK5 and CDK8 Proteins as Prognostic and Potential Biomarkers in Colorectal Cancer Patients
por: Wang, Dan, et al.
Publicado: (2022)

Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells
por: Ogata, Ryohei, et al.
Publicado: (2020)

Natural chalcones as dual inhibitors of HDACs and NF-κB
por: ORLIKOVA, B., et al.
Publicado: (2012)

Small Molecule NF-κB Pathway Inhibitors in Clinic
por: Ramadass, Venkataramanan, et al.
Publicado: (2020)

The Candida albicans Cdk8-dependent phosphoproteome reveals repression of hyphal growth through a Flo8-dependent pathway
por: Hollomon, Jeffrey M., et al.
Publicado: (2022)

Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines
por: Coxon, Christopher R., et al.
Publicado: (2016)

Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence
por: Yang, C, et al.
Publicado: (2017)

Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors
por: Sofi, Shazia, et al.
Publicado: (2022)

NF-κB Dependent Chemokine Signaling in Pancreatic Cancer
por: Geismann, Claudia, et al.
Publicado: (2019)

Allostery governs Cdk2 activation and differential recognition of CDK inhibitors
por: Majumdar, Abir, et al.
Publicado: (2021)

CDK8 inhibitors antagonize HIV-1 reactivation and promote provirus latency in T cells
por: Horvath, Riley M., et al.
Publicado: (2023)

CDK8-Novel Therapeutic Opportunities
por: Menzl, Ingeborg, et al.
Publicado: (2019)

Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor
por: Nishio, H, et al.
Publicado: (2014)

Quantitative imaging assay for NF-κB nuclear translocation in primary human macrophages
por: Noursadeghi, Mahdad, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_55lkcdjfdi5ip8umdslnjm6l9m